Frontiers in pharmacology

Nano letters

physiology & behavior

progress in neuro-psychopharmacology & biological psychiatry

Molecules (Basel, Switzerland)

PsyCh journal

Frontiers in psychiatry

Molecular brain

australasian psychiatry : bulletin of royal australian and new zealand college of psychiatrists

ACS omega

BMJ open

journal of clinical medicine

neural networks : the official journal of the international neural network society

Journal of affective disorders

psychiatry research

neuroscience letters

journal of pharmaceutical sciences

Rapid communications in mass spectrometry : RCM

Asian journal of psychiatry

jmir research protocols

Health technology assessment (Winchester, England)

nature genetics

bipolar disorders

Biomolecules

neuroimage clinical

european psychiatry : the journal of the association of european psychiatrists

Frontiers in endocrinology

lipids in health and disease

expert opinion on therapeutic patents

The American journal of managed care

BMC psychiatry

advances in experimental medicine and biology

Turk psikiyatri dergisi = Turkish journal of psychiatry

l'encephale

Schizophrenia research

European archives of psychiatry and clinical neuroscience

JMIR formative research

plastic and reconstructive surgery

international journal of mental health nursing

journal of clinical psychology

artificial intelligence in medicine

journal of biomedical informatics

neuron

psychiatric services (washington, dc)

psychiatry investigation

schizophrenia bulletin

Human brain mapping

The Journal of nervous and mental disease

nordic journal of psychiatry

journal of the formosan medical association = taiwan yi zhi

The International journal of social psychiatry

the american journal of psychiatry

Biological psychiatry

cortex; a journal devoted to the study of the nervous system and behavior

twin research and human genetics : the official journal of the international society for twin studies

the british journal of psychiatry : the journal of mental science

BJPsych open

nutrition reviews

the psychiatric quarterly

biological psychiatry cognitive neuroscience and neuroimaging

clinical rehabilitation

antioxidants & redox signaling

european neuropsychopharmacology : the journal of the european college of neuropsychopharmacology

clinical psychology & psychotherapy

biomolecular concepts

general hospital psychiatry

schizophrenia research cognition

Behavioural and cognitive psychotherapy

journal of hospice and palliative nursing : jhpn : the official journal of the hospice and palliative nurses association

genes, brain, and behavior

Psychiatric services (Washington, D.C.)

[1] Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

[2] 3D-CNN based discrimination of schizophrenia using resting-state fMRI.

[3] Constituents of Saffron (Crocus sativus L.) as Potential Candidates for the Treatment of Anxiety Disorders and Schizophrenia.

[4] Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.

[5] Social cognition in schizophrenia: A network-based approach to a Taiwanese version of the Reading the Mind in the Eyes test.

[6] Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.

[7] Insulin-signaling abnormalities in drug-naïve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin.

[8] A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.

[9] Reduced cortical somatostatin gene expression in a rat model of maternal immune activation.

[10] Test-retest reliability, concurrent validity and correlates of the two-minute walk test in outpatients with psychosis.

[11] GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

[12] A review of autobiographical memory studies on patients with schizophrenia spectrum disorders.

[13] Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.

[14] Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia.

[15] Schizophrenia, recovery and the self: An introduction to the special issue on metacognition.

[16] Metacognition over time is related to neurocognition, social cognition, and intrapsychic foundations in psychosis.

[17] Metacognitive function and fragmentation in schizophrenia: Relationship to cognition, self-experience and developing treatments.

[18] Cognitive and metacognitive factors predict engagement in employment in individuals with first episode psychosis.

[19] Trace elements in schizophrenia: a systematic review and meta-analysis of 39 studies (N = 5151 participants).

[20] Assessing metacognitive and help-seeking strategies in schizophrenia: design and psychometric validation of the Versailles Metacognitive Strategies Evaluation Questionnaire.

[21] Disruptions of frontoparietal control network and default mode network linking the metacognitive deficits with clinical symptoms in schizophrenia.

[22] Dynamic relationships between emotional distress, persecutory ideation, and metacognition in schizophrenia.

[23] Effects of a Korean version of the metacognitive training program for outpatients with schizophrenia on theory of mind, positive symptoms, and interpersonal relationships.

[24] Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation.

[25] Transforming a Face-to-Face Legacy Intervention to a Web-Based Legacy Intervention for Children With Advanced Cancer.

[26] Improving the Detection of Individuals at Clinical Risk for Psychosis in the Community, Primary and Secondary Care: An Integrated Evidence-Based Approach.

[27] Abnormal dynamic functional connectivity between speech and auditory areas in schizophrenia patients with auditory hallucinations.

[28] Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder.

[29] Dynamic Causal Modelling suggests impaired effective connectivity in patients with schizophrenia spectrum disorders during gesture-speech integration.

[30] The Mediating Effect of Depression and Disability in the Relationship Between Schizophreniaand Self-Esteem.

[31] A New Test for Irony Detection: The Influence of Schizotypal, Borderline, and Autistic Personality Traits.

[32] Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

[33] A review on neural network models of schizophrenia and autism spectrum disorder.

[34] Phosphodiesterase 10 (PDE10) inhibitors: an updated patent review (2014-present).

[35] Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity.

[36] Behavioral abnormalities and phosphorylation deficits of extracellular signal-regulated kinases 1 and 2 in rat offspring of the maternal immune activation model.

[37] Fetal Origins of Mental Disorders? An Answer Based on Mendelian Randomization.

[38] 'I wanted my child dead' - Physical, social, cognitive, emotional and spiritual life stories of Turkish parents who give care to their children with schizophrenia: A qualitative analysis based on empowerment approach.

[39] Implementing the Latvian Early Intervention Program (LAT-EIP) for Patients With Schizophrenia Spectrum First-Episode Psychosis: Study Protocol.

[40] [Integrating close relatives of people experiencing schizophrenia in the mental health system].

[41] A Pattern of Cognitive Deficits Stratified for Genetic and Environmental Risk Reliably Classifies Patients With Schizophrenia From Healthy Control Subjects.

[42] Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases.

[43] A claims-based algorithm to reduce relapse and cost in schizophrenia.

[44] Focused Ethnographic Examination of Barriers to Use of Long-Acting Injectable Antipsychotics.

[45] Strategic Timing of Glial Expression Results in Either Schizophrenia-Like or Parkinsonian Behavior in Mice.

[46] Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

[47] The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders.

[48] Assessing the developmental trajectory of mouse models of neurodevelopmental disorders: Social and communication deficits in mice with Neurexin 1α deletion.

[49] Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study.

[50] CUL3 Deficiency Causes Social Deficits and Anxiety-like Behaviors by Impairing Excitation-Inhibition Balance through the Promotion of Cap-Dependent Translation.

[51] Executive functions in schizophrenia aging: Differential effects of age within specific executive functions.

[52] Stigmatizing Attitudes Towards Mental Disorders Among Non-Mental Health Professionals in Six General Hospitals in Hunan Province.

[53] An evaluation of a psychoeducation programme for emotion identification and expression in individuals diagnosed with schizophrenia.

[54] Association of the Promoter Haplotype of IFN-γ-Inducible Protein 16 Gene with Schizophrenia in a Korean Population.

[55] Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.

[56] Self-reported emotion regulation difficulties in people with psychosis compared with non-clinical controls: A systematic literature review.

[57] The brief negative symptom scale in translation: A review of psychometric properties and beyond.

[58] [What support of young presenting a first psychotic episode, when schooling is being challenged?]

[59] Decrease in 130 kDa- amyloid protein precursor protein (app) and APP protein ratio in schizophrenia platelets.

[60] Cognitive and clinical predictors of community functioning across the psychoses.

[61] Loneliness and psychotic experiences in a general population sample.

[62] How does awareness of cognitive impairment impact motivation and treatment outcomes during cognitive remediation for schizophrenia?

[63] COVID-19: Considering the prevalence of schizophrenia in the coming decades.

[64] Diagnostic conversion from unipolar depression tobipolar disorder, schizophrenia,or schizoaffective disorder:a nationwide prospective15-yearregister study on 43,495 inpatients.

[65] Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966.

[66] Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness.

[67] Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population.

[68] Using Language Processing and Speech Analysis for the Identification of Psychosis and Other Disorders.

[69] Natural Language Processing Tools for Assessing Progress and Outcome of Two Veteran Populations: Insights from a Novel Online Intervention for Post Traumatic Growth.

[70] Impact of an Electronic Cigarette on Smoking Reduction and Cessation in Schizophrenic Smokers: A Prospective 12-Month Pilot Study

[71] Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.

[72] poor executive functioning associated with the risk of aggressive behavior recidivism in the forensic community in schizophrenic patients

[73] february 2014 phoenix pulmonary journal club: smoking cessation

[74] metaphor in psychosis: on the possible convergence of lacanian theory and neuro-scientific research

[75] gray matter volumetric abnormalities associated with the onset of psychosis

[76] psychiatric diseases: need for an increased awareness among the anesthesiologists

[77] ocular convergence deficits in schizophrenia

[78] symptom overlap and screening for symptoms of attention-deficit/hyperactivity disorder and psychosis risk in help-seeking psychiatric patients

[79] exposure to prenatal infection and risk of schizophrenia

[80] physical functional capacity and c-reactive protein in schizophrenia

[81] human endogenous retroviruses as pathogenic factors in the development of schizophrenia

[82] brain state-dependent abnormal lfp activity in the auditory cortex of a schizophrenia mouse model

[83] neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? insights from genetic rodent models

[84] asymmetric drug-induced parkinsonism and psychopathology: a prospective naturalistic study in long-stay psychiatric patients

[85] global economic burden of schizophrenia: response to authors’ reply

[86] d-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine

[87] a comparison between the mini-mental state examination and the montreal cognitive assessment test in schizophrenia

[88] treatment of early onset schizophrenia: recent trends, challenges and future considerations

[89] tata negara dan peradaban islam: antara cita-cita dan ilusi

[90] using multivariate machine learning methods and structural mri to classify childhood onset schizophrenia and healthy controls

[91] cotidiano de portadores de esquizofrenia após uso de clozapina e acompanhamento grupal el cotidiano de portadores de esquizofrenia después del uso de clozapina y acompañamiento del grupo daily life of schizofrenia patients after the use of clozapine and group follow up

[92] a randomized-controlled trial with a canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia

[93] schizophrenia spectrum disorders show reduced specificity and less positive events in mental time travel

[94] bringing the ‘self’ into focus: conceptualising the role of self-experience for understanding and working with distressing voices

[95] the quality of life in inpatients with chronic schizophrenia

[96] synaptic plasticity, neural circuits and the emerging role of altered short-term information processing in schizophrenia

[97] neural activity changes underlying the working memory deficit in alpha-camkii heterozygous knockout mice

[98] persistent deficits in hippocampal synaptic plasticity accompany losses of hippocampus-dependent memory in a rodent model of psychosis

[99] enhancing neuroplasticity to augment cognitive remediation in schizophrenia

[100] caracterización de gemelos con esquizofrenia en el municipio de santiago de cuba characterization of twins with schizophrenia in the municipality of santiago de cuba

[101] neural network reorganization analysis during an auditory oddball task in schizophrenia using wavelet entropy